Propanc Biopharma, Inc. PPCB
1.80 USD -0.04 -2.07%
As of Nov 2, 1:55 PM ET
1.79 52-week range 315.00
- YTD
- -98.66%
- 1 year
- -99.42%
- Open
- 1.96
- Prev close
- 1.84
- Mkt cap
- 1.87M
- Vol
- 20.36K
- Avg vol
- 189.01K
- EPS
- -176.20
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.80
- High
- 1.96
- Earnings
- Sep 27, 2023
5m chart
Chart tools
Chart is warming up
The five-minute interval price history for PPCB has not been loaded yet. Try again in a moment.
Altman Z-Score
-19.74 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
P/E -0.1×
P/S 0.0×
P/B 0.2×
P/FCF -0.3×
EV/EBITDA -0.0×
EV/Sales 0.0×
FCF Yield -337.1%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -200.6%
ROIC -192.4%
ROA -147.6%
Revenue 0.0%
Operating Income 68.3%
EPS (diluted) 95.3%
Free Cash Flow -1302.5%
Current Ratio 2.5×
Quick Ratio 2.5×
Debt / Equity 0.0×
Net Debt / EBITDA 0.0×
Interest Coverage -42.2×
Dividend Yield 55.3%
Payout Ratio -4.9%
Annual · latest fiscal year ends 2026-06-30
